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SUMMARY. A simple and sensitive LC–ESI–MS method for determination of norvancomycin in plasma
was developed and validated over the concentration range of 20–2,000 ng/mL. After addition of van-
comycin as internal standard (IS), protein precipitation with 5 % trichloroacetic acid was employed for
the sample preparation. Chromatographic separation was performed on a Zorbax SB-C18 (100 mm×2.1
mm, 3.5 μm) column with 10:90 (v/v) acetonitrile–0.1 % formic acid as mobile phase. The MS data acqui-
sition was accomplished by selective ions monitoring (SIM) mode with positive electrospray ionization
(ESI) interface. The limit of quantification (LOQ) was 20 ng/mL. For inter-day and intra-day tests, the
precision (RSD) for the entire validation was less than 12 %. The developed method was successfully ap-
plied to pharmacokinetic studies of norvancomycin in rats following single intravenous administration
dose of 10 mg/Kg.
